Figure 7, Work flow for the identification of hits as agonists of the relaxin receptor 1 (RXFP1) in the qHTS screening campaign
Jingbo Xiao(National Center for Advancing Translational Sciences), Juan Marugán(National Institutes of Health), Noel Southall(National Institutes of Health), Irina U. Agoulnik(University of South Florida), Alexander I. Agoulnik(Florida International University), Marc Ferrer(National Institute of Biomedical Innovation, Health and Nutrition), Xin Hu, Wei Xing Zheng(Western Sydney University), Zaohua Huang(Florida International University), Catherine Z. Chen(National Institutes of Health)
Unknown
May 8, 2013
Cited by 0
Related Papers
Rethinking dog domestication by integrating genetics, archeology, and biogeography
|Proceedings of the National Academy of Sciences|2012|534
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
A transgenic insertion upstream of Sox9 is associated with dominant XX sex reversal in the mouse
|Nature Genetics|2000|351
Caveolin-1 Is Down-Regulated in Human Ovarian Carcinoma and Acts as a Candidate Tumor Suppressor Gene
|American Journal Of Pathology|2001|279
Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screening
|Science Translational Medicine|2019|259